{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:56:23Z","timestamp":1792000583323,"version":"4.4.0"},"reference-count":54,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2022,6,14]]},"abstract":"<jats:p>Background: Brain cholesterol levels are tightly regulated but increasing evidence indicates that cholesterol metabolism may drive Alzheimer\u2019s disease (AD)-associated pathological changes. Recent advances in understanding of mitochondrial dysfunction in AD brain have presented a vital role played by mitochondria in oxysterol biosynthesis and their involvement in pathophysiology. Oxysterol accumulation in brain is controlled by various enzymatic pathways including sulfation. While research into oxysterol is under the areas of active investigation, there is less evidence for oxysterol sulfate levels in human brain. Objective: This study investigates the hypothesis that AD brain oxysterol detoxification via sulfation is impaired in later stages of disease resulting in oxysterol accumulation. Methods: Lipids were extracted from postmortem frozen brain tissue and cerebrospinal (CSF) from late- (Braak stage III-IV) and early- (Braak stage I-II) stage AD patients. Samples were spiked with internal standards prior to lipid extraction. Oxysterols were enriched with a two-step solid phase extraction using a polymeric SPE column and further separation was achieved by LC-MS\/MS. Results: Oxysterols, 26-hydroxycholesterol (26-OHC), 25-hydroxycholesterol (25-OHC), and 7-oxycholesterol levels were higher in brain tissue and mitochondria extracted from late-stage AD brain tissue except for 24S-hydroxycholesterol, which was decreased in late AD. However, oxysterol sulfates are significantly lower in the AD frontal cortex. Oxysterols, 25-OHC, and 7-oxocholesterol was higher is CSF but 26-OHC and oxysterol sulfate levels were not changed. Conclusion: Our results show oxysterol metabolism is altered in AD brain mitochondria, favoring synthesis of 26-OHC, 25-OHC, and 7-oxocholesterol, and this may influence brain mitochondrial function and acceleration of the disease.<\/jats:p>","DOI":"10.3233\/jad-220083","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T12:21:50Z","timestamp":1651234910000},"page":"1527-1536","source":"Crossref","is-referenced-by-count":30,"title":["Oxysterols and Oxysterol Sulfates in Alzheimer\u2019s Disease Brain and Cerebrospinal Fluid"],"prefix":"10.1177","volume":"87","author":[{"given":"Irundika H.K.","family":"Dias","sequence":"first","affiliation":[{"name":"Aston Medical School, College of Health and Life Sciences, Aston University, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala","family":"Shokr","sequence":"additional","affiliation":[{"name":"Manchester Pharmacy School, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freya","family":"Shephard","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine and Science, University of Nottingham, Nottingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Chakrabarti","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine and Science, University of Nottingham, Nottingham, United Kingdom"},{"name":"MRC Versus Arthritis Centre for Musculoskeletal Ageing Research, Nottingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-220083_ref1","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/461895a","article-title":"Alzheimer\u2019s disease","volume":"461","author":"Mucke","year":"2009","journal-title":"Nature"},{"key":"10.3233\/JAD-220083_ref2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-220083_ref3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pathophys.2006.05.004","article-title":"Oxidative stress in Alzheimer\u2019s disease","volume":"13","author":"Chauhan","year":"2006","journal-title":"Pathophysiology"},{"key":"10.3233\/JAD-220083_ref4","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.plipres.2016.09.002","article-title":"Oxysterols: From cholesterol metabolites to key mediators","volume":"64","author":"Mutemberezi","year":"2016","journal-title":"Prog Lipid Res"},{"key":"10.3233\/JAD-220083_ref5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.arr.2014.09.006","article-title":"Involvement of oxysterols in age-related diseases and ageing processes","volume":"18","author":"Zarrouk","year":"2014","journal-title":"Ageing Res Rev"},{"key":"10.3233\/JAD-220083_ref6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41398-018-0221-8","article-title":"The genetic risk of Alzheimer\u2019s disease beyond APOE \u025b4: Systematic review of Alzheimer\u2019s genetic risk scores","volume":"8","author":"Stocker","year":"2018","journal-title":"Transl Psychiatry"},{"key":"10.3233\/JAD-220083_ref7","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1161\/01.ATV.0000120374.59826.1b","article-title":"Brain cholesterol: Long secret life behind a barrier","volume":"24","author":"Bj\u00f6rkhem","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.3233\/JAD-220083_ref8","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1042\/BST20140164","article-title":"Hypercholesterolaemia-induced oxidative stress at the blood\u2013brain barrier","volume":"42","author":"Dias Irundika","year":"2014","journal-title":"Biochem Soc Trans"},{"key":"10.3233\/JAD-220083_ref9","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3390\/antiox10050740","article-title":"The controversial role of 24-S-hydroxycholesterol in Alzheimer\u2019s disease","volume":"10","author":"Gamba","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.3233\/JAD-220083_ref10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2796.2006.01725.x","article-title":"Crossing the barrier: Oxysterols as cholesterol transporters and metabolic modulators in the brain","volume":"260","author":"Bj\u00f6rkhem","year":"2006","journal-title":"J Intern Med"},{"key":"10.3233\/JAD-220083_ref11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.redox.2016.09.001","article-title":"Changes in brain oxysterols at different stages of Alzheimer\u2019s disease: Their involvement in neuroinflammation","volume":"10","author":"Testa","year":"2016","journal-title":"Redox Biol"},{"key":"10.3233\/JAD-220083_ref12","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/sj.mp.4001109","article-title":"Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer\u2019s disease","volume":"7","author":"K\u00f6lsch","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-220083_ref13","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.beem.2012.05.002","article-title":"Role of mitochondria in steroidogenesis","volume":"26","author":"Papadopoulos","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.3233\/JAD-220083_ref14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3233\/JAD-200105","article-title":"Cerebrospinal fluid 7-ketocholesterol level is associated with amyloid-\u03b2 42 and white matter microstructure in cognitively healthy adults","volume":"76","author":"Iriondo","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220083_ref15","doi-asserted-by":"crossref","first-page":"101380","DOI":"10.1016\/j.redox.2019.101380","article-title":"7-Ketocholesterol in disease and aging","volume":"29","author":"Anderson","year":"2020","journal-title":"Redox Biol"},{"key":"10.3233\/JAD-220083_ref16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-2275(20)32052-6","article-title":"Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients","volume":"41","author":"L\u00fctjohann","year":"2000","journal-title":"J Lipid Res"},{"key":"10.3233\/JAD-220083_ref17","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.3390\/cells10092301","article-title":"Impact of oxysterols on cell death, proliferation, and differentiation induction: Current status","volume":"10","author":"de Freitas","year":"2021","journal-title":"Cells"},{"key":"10.3233\/JAD-220083_ref18","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1210\/endo.142.7.8244","article-title":"Cholesterol and hydroxycholesterol sulfotransferases: Identification, distinction from dehydroepiandrosterone sulfotransferase, and differential tissue expression","volume":"142","author":"Javitt","year":"2001","journal-title":"Endocrinology"},{"key":"10.3233\/JAD-220083_ref19","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1194\/jlr.R300005-JLR200","article-title":"Cholesterol sulfate in human physiology: What\u2019s it all about?","volume":"44","author":"Strott","year":"2003","journal-title":"J Lipid Res"},{"key":"10.3233\/JAD-220083_ref20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fendo.2011.00050","article-title":"Neuroprotective actions of neurosteroids","volume":"2","author":"Borowicz","year":"2011","journal-title":"Front Endocrinol"},{"key":"10.3233\/JAD-220083_ref21","doi-asserted-by":"crossref","first-page":"E123","DOI":"10.1152\/ajpendo.00552.2013","article-title":"Sulfation of 25-hydroxycholesterol regulates lipid metabolism, inflammatory responses, and cell proliferation","volume":"306","author":"Ren","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.3233\/JAD-220083_ref22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/metabo11010009","article-title":"Cholesterol metabolites 25-hydroxycholesterol and 25-hydroxycholesterol 3-sulfate are potent paired regulators: From discovery to clinical usage","volume":"11","author":"Wang","year":"2021","journal-title":"Metabolites"},{"key":"10.3233\/JAD-220083_ref23","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1194\/jlr.D061499","article-title":"Simultaneous quantification of cholesterol sulfate, androgen sulfates, and progestagen sulfates in human serum by LC-MS\/MS","volume":"56","author":"S\u00e1nchez-Guijo","year":"2015","journal-title":"J Lipid Res"},{"key":"10.3233\/JAD-220083_ref24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1194\/jlr.M055608","article-title":"High levels of oxysterol sulfates in serum of patients with steroid sulfatase deficiency","volume":"56","author":"S\u00e1nchez-Guijo","year":"2015","journal-title":"J Lipid Res"},{"key":"10.3233\/JAD-220083_ref25","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1194\/jlr.M700018-JLR200","article-title":"Oxysterols are substrates for cholesterol sulfotransferase","volume":"48","author":"Fuda","year":"2007","journal-title":"J Lipid Res"},{"key":"10.3233\/JAD-220083_ref26","doi-asserted-by":"crossref","first-page":"17713","DOI":"10.18632\/aging.103937","article-title":"Sex specific inflammatory profiles of cerebellar mitochondria are attenuated in Parkinson\u2019s disease","volume":"12","author":"Ingram","year":"2020","journal-title":"Aging"},{"key":"10.3233\/JAD-220083_ref27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.redox.2018.02.014","article-title":"Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia","volume":"16","author":"Dias","year":"2018","journal-title":"Redox Biol"},{"key":"10.3233\/JAD-220083_ref28","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-220083_ref29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.chemphyslip.2019.03.009","article-title":"Sulfate-based lipids: Analysis of healthy human fluids and cell extracts","volume":"221","author":"Dias","year":"2019","journal-title":"Chem Phys Lipids"},{"key":"10.3233\/JAD-220083_ref30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-220083_ref31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.freeradbiomed.2014.07.012","article-title":"Oxidized LDL lipids increase \u03b2-amyloid production by SH-SY5Y cells through glutathione depletion and lipid raft formation","volume":"75","author":"Dias","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"10.3233\/JAD-220083_ref32","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/acel.12206","article-title":"Up-regulation of \u03b2-amyloidogenesis in neuron-like human cells by both 24- and 27-hydroxycholesterol: Protective effect of N-acetyl-cysteine","volume":"13","author":"Gamba","year":"2014","journal-title":"Aging Cell"},{"key":"10.3233\/JAD-220083_ref33","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3233\/JAD-2011-101512","article-title":"Upregulation of brain renin angiotensin system by 27-hydroxycholesterol in Alzheimer\u2019s disease","volume":"24","author":"Mateos","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220083_ref34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220083_ref35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: A practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-220083_ref36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: Recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-220083_ref37","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbrc.2007.05.033","article-title":"Regulation of \u03b1- and \u03b2-secretase activity by oxysterols: Cerebrosterol stimulates processing of APP via the \u03b1-secretase pathway","volume":"359","author":"Famer","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JAD-220083_ref38","doi-asserted-by":"crossref","first-page":"17290","DOI":"10.1523\/JNEUROSCI.2619-13.2013","article-title":"The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors","volume":"33","author":"Paul","year":"2013","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-220083_ref39","doi-asserted-by":"crossref","first-page":"e68534","DOI":"10.1371\/journal.pone.0068534","article-title":"Is it possible to improve memory function by upregulation of the cholesterol 24S-hydroxylase (CYP46A1) in the brain?","volume":"8","author":"Maioli","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JAD-220083_ref40","doi-asserted-by":"crossref","first-page":"11394","DOI":"10.1073\/pnas.0805556105","article-title":"Biphasic requirement for geranylgeraniol in hippocampal long-term potentiation","volume":"105","author":"Kotti","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"10.3233\/JAD-220083_ref41","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jsbmb.2019.03.003","article-title":"Alterations in cholesterol metabolism as a risk factor for developing Alzheimer\u2019s disease: Potential novel targets for treatment","volume":"190","author":"Loera-Valencia","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.3233\/JAD-220083_ref42","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1111\/j.1471-4159.2007.04689.x","article-title":"Oxysterols, cholesterol homeostasis, and Alzheimer disease","volume":"102","author":"Vaya","year":"2007","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-220083_ref43","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41537-020-00121-4","article-title":"Assessment of brain cholesterol metabolism biomarker 24S-hydroxycholesterol in schizophrenia","volume":"6","author":"Chiappelli","year":"2020","journal-title":"NPJ Schizophrenia"},{"key":"10.3233\/JAD-220083_ref44","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.mam.2009.02.001","article-title":"Oxysterols and neurodegenerative diseases","volume":"30","author":"Bj\u00f6rkhem","year":"2009","journal-title":"Mol Aspects Med"},{"key":"10.3233\/JAD-220083_ref45","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1194\/jlr.M600529-JLR200","article-title":"Novel route for elimination of brain oxysterols across the blood-brain barrier: Conversion into 7alpha-hydroxy-3-oxo-4-cholestenoic acid","volume":"48","author":"Meaney","year":"2007","journal-title":"J Lipid Res"},{"key":"10.3233\/JAD-220083_ref46","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1194\/jlr.M200434-JLR200","article-title":"Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers","volume":"44","author":"Leoni","year":"2003","journal-title":"J Lipid Res"},{"key":"10.3233\/JAD-220083_ref47","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1515\/CCLM.2004.034","article-title":"Diagnostic use of cerebral and extracerebral oxysterols","volume":"42","author":"Leoni","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"10.3233\/JAD-220083_ref48","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1084\/jem.20160534","article-title":"27-Hydroxycholesterol impairs neuronal glucose uptake through an IRAP\/GLUT4 system dysregulation","volume":"214","author":"Ismail","year":"2017","journal-title":"J Exp Med"},{"key":"10.3233\/JAD-220083_ref49","doi-asserted-by":"crossref","first-page":"18415","DOI":"10.1074\/jbc.M313615200","article-title":"Rapid hepatic metabolism of 7-ketocholesterol by 11beta-hydroxysteroid dehydrogenase type 1: Species-specific differences between the rat, human, and hamster enzyme","volume":"279","author":"Schweizer","year":"2004","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-220083_ref50","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.molcel.2018.08.034","article-title":"Cilia-associated oxysterols activate smoothened","volume":"72","author":"Raleigh","year":"2018","journal-title":"Mol Cell"},{"key":"10.3233\/JAD-220083_ref51","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/ars.2006.8.375","article-title":"Early involvement of ROS overproduction in apoptosis induced by 7-ketocholesterol","volume":"8","author":"Leonarduzzi","year":"2006","journal-title":"Antioxid Redox Signal"},{"key":"10.3233\/JAD-220083_ref52","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jsbmb.2016.03.029","article-title":"Mitochondrial dysfunctions in 7-ketocholesterol-treated 158N oligodendrocytes without or with \u03b1-tocopherol: Impacts on the cellular profil of tricarboxylic cycle-associated organic acids, long chain saturated and unsaturated fatty acids, oxysterols, cholesterol and cholesterol precursors","volume":"169","author":"Leoni","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.3233\/JAD-220083_ref53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/tpj.2017.4","article-title":"Sulfotransferase 1A3\/4 copy number variation is associated with neurodegenerative disease","volume":"18","author":"Butcher","year":"2018","journal-title":"Pharmacogenomics J"},{"key":"10.3233\/JAD-220083_ref54","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.33549\/physiolres.933160","article-title":"Reduced sulfotransferase SULT2A1 activity in patients with Alzheimer\u2019s disease","volume":"64","author":"Vankov\u00e1","year":"2015","journal-title":"Physiol Res"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-220083","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:06:05Z","timestamp":1777370765000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-220083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,14]]},"references-count":54,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jad-220083","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,14]]}}}